Unspecified “production issues” are cited for what Procurement Minister Anita Anand says is a temporary problem delivering the Pfizer-BioNTech vaccine to Canada. Anand said Friday the US drug-maker is temporarily reducing deliveries because of issues with its European production lines. She said that while the company says it will still be able to deliver four million doses by the end of March, that is no longer guaranteed.
